Equities

Aarti Drugs Ltd

AARTIDRUGS:NSI

Aarti Drugs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)524.90
  • Today's Change4.90 / 0.94%
  • Shares traded78.62k
  • 1 Year change-8.90%
  • Beta1.0738
Data delayed at least 15 minutes, as of Sep 20 2024 11:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments198197342
Total Receivables, Net7,0528,6598,325
Total Inventory4,8595,1635,259
Prepaid expenses------
Other current assets, total1,0988997.18
Total current assets13,20714,91813,934
Property, plant & equipment, net10,3518,6227,665
Goodwill, net------
Intangibles, net3682431.53
Long term investments200188195
Note receivable - long term197242284
Other long term assets0.000.000.00
Total assets24,32424,21422,080
LIABILITIES
Accounts payable4,2554,8034,687
Accrued expenses304447
Notes payable/short-term debt2,14703,563
Current portion long-term debt/capital leases7334,038461
Other current liabilities, total791610642
Total current liabilities7,9559,4959,401
Total long term debt2,7622,0511,404
Total debt5,6436,0895,428
Deferred income tax757710724
Minority interest4.062.33(0.6)
Other liabilities, total2932188
Total liabilities11,50812,29011,716
SHAREHOLDERS EQUITY
Common stock919926926
Additional paid-in capital------
Retained earnings (accumulated deficit)11,80710,9109,339
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total898898
Total equity12,81511,92410,364
Total liabilities & shareholders' equity24,32424,21422,080
Total common shares outstanding929393
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.